First Phase 3 test of coronavirus vaccine candidate begins in US

An investigational vaccine developed by drugmaker Moderna and the National Institute of Allergy and Infectious Diseases began Phase 3 trials on Monday, becoming the first candidate to reach that step in testing.About 30,000 adult volunteers are set to be enrolled in the trial, according to CNN, which added that the first patient was dosed at a site in Savannah, Ga. A trial group will receive two 100 microgram injections of the candidate while…